Zobrazeno 1 - 10
of 302
pro vyhledávání: '"Patrick A Boland"'
Autor:
Ritesh Kumar, Jongmyung Kim, Matthew P. Deek, Mariam F. Eskander, Prateek Gulhati, Haejin In, Timothy Kennedy, Mihir M. Shah, Miral S. Grandhi, Lyudmyla Berim, Kristen R. Spencer, Russell C. Langan, Howard S. Hochster, Patrick M. Boland, Salma K. Jabbour
Publikováno v:
Current Oncology, Vol 30, Iss 7, Pp 6432-6446 (2023)
Oncological outcomes are improving in gastrointestinal cancer with advancements in systemic therapies, and there is notable potential in combining immunotherapy and radiation therapy (RT) to allow for further improvements. Various preclinical and ear
Externí odkaz:
https://doaj.org/article/729b9f4c7e68413787e8c6f05e59d79e
Autor:
Emma Vail, Ankur P. Choubey, H. Richard Alexander, David A. August, Abril Berry, Patrick M. Boland, Mariam F. Eskander, Miral S. Grandhi, Brittany Haliani, Haejin In, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Henry A. Pitt, Shridar Ganesan, Brett L. Ecker
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Several cytotoxic chemotherapies have demonstrated efficacy in improving recurrence‐free survival (RFS) following resection of Stage II–IV colorectal cancer (CRC). However, the temporal dynamics of response to such adjuvant th
Externí odkaz:
https://doaj.org/article/c7d6c4918adb470e867663524ca12d6d
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Timely diagnosis and management of iron deficiency anemia (IDA) in colorectal cancer (CRC) patients improves overall quality of life and survival. This study assessed the proportion of CRC patients who were formally diagnosed with
Externí odkaz:
https://doaj.org/article/b4962622a19d461f8d28ea9ec65561de
Autor:
Karl Brendel, Tanios Bekaii‐Saab, Patrick M Boland, Farshid Dayyani, Andrew Dean, Teresa Macarulla, Fiona Maxwell, Kabir Mody, Anna Pedret‐Dunn, Zev A Wainberg, Bin Zhang
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 12, Pp 1550-1563 (2021)
Abstract Liposomal irinotecan is a liposomal formulation of irinotecan, which prolongs circulation of irinotecan and its active metabolite SN‐38. A population pharmacokinetic (PK) model was developed based on data from seven studies (N = 440). Adeq
Externí odkaz:
https://doaj.org/article/e00fe99ece8b44b19ef2e7b6979ee045
Autor:
Meredith K. Bartelstein, Jonathan A. Forsberg, Jessica A. Lavery, Mohamed A. Yakoub, Samuel Akhnoukh, Patrick J. Boland, Nicola Fabbri, John H. Healey
Publikováno v:
Journal of Bone Oncology, Vol 34, Iss , Pp 100433- (2022)
Aims: Our objective was to determine if preoperative patient-reported assessments are associated with survival after surgery for stabilization of skeletal metastases. Patients and Methods: All patients with metastatic cancer to bone and indications f
Externí odkaz:
https://doaj.org/article/9d2e85ced08142adb2219ca40f2080b2
Autor:
Xiang Ling, Wenjie Wu, Ieman A. M. Aljahdali, Jianqun Liao, Sreevidya Santha, Christos Fountzilas, Patrick M. Boland, Fengzhi Li
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 5, Pp n/a-n/a (2022)
ABSTRACT Background Pancreatic ductal adenocarcinoma (PDAC), a difficult‐to‐treat cancer, is expected to become the second‐largest cause of cancer‐related deaths by 2030, while colorectal cancer (CRC) is the third most common cancer and the t
Externí odkaz:
https://doaj.org/article/ff7f5691688d42929e672fe9ee33b6d4
Autor:
Dung T. Le, Luis A. Diaz, Tae Won Kim, Eric Van Cutsem, Ravit Geva, Dirk Jäger, Hiroki Hara, Matthew Burge, Bert H. O’Neil, Petr Kavan, Takayuki Yoshino, Rosine Guimbaud, Hiroya Taniguchi, Elena Élez, Salah-Eddin Al-Batran, Patrick M. Boland, Yi Cui, Pierre Leconte, Patricia Marinello, Thierry André
Publikováno v:
European Journal of Cancer. 186:185-195
Autor:
Josephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, Yingjuan Xu, Ivelise Rijo, Jacklyn Casanova, Liliana Villafania, Jamal Benhamida, Ciara M. Kelly, William D. Tap, Patrick J. Boland, Nicola Fabbri, John H. Healey, Marc Ladanyi, Chao Lu, Meera Hameed
Publikováno v:
Cancer Research Communications. 3:431-443
Dedifferentiated chondrosarcoma (DDCS) is a rare high-grade chondrosarcoma characterized by a well-differentiated chondrosarcoma (WDCS) component that abruptly transitions to a high-grade, noncartilaginous sarcomatous component. To date, the molecula
Publikováno v:
Journal of Surgical Oncology. 126:906-912
There have been enormous advances in the treatment of bone tumors over the past half-century. The most notable of these has been the transition from amputation as the standard of care to limb salvage surgery. This transition is the result of advances
Autor:
Meera Hameed, Chao Lu, Marc Ladanyi, John H. Healey, Nicola Fabbri, Patrick J. Boland, William D. Tap, Ciara M. Kelly, Jamal Benhamida, Liliana Villafania, Jacklyn Casanova, Ivelise Rijo, Yingjuan Xu, Abhinita Mohanty, Khedoujia Nafa, Josephine Kam Tai Dermawan
Overall and progression-free survival in DDCS patients with or without TERT alterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62562774111674b044b3071013d09415
https://doi.org/10.1158/2767-9764.22546951.v1
https://doi.org/10.1158/2767-9764.22546951.v1